2Kuwana M,Kawakami Y,Ikeda Y.Suppr ession of autoreactive T2 cell response to glycoprotein Ⅱ b/Ⅲ a by blockade of CD40/CD154 interaction:implications for treatment of immune thrombocytopenic purpura.Blood,2003,101:621-623.
3Ivanov Ⅱ,Mekenzie BS,Zhou L,et al.The orphan nuclear receptor ROR-γt directs the differentiation program of proinflammatory IL17^+T helper cells.Cell,2006,126:1121 -1133.
4Sakakura M,Wada H,Tawara I,et al.Reduced CD4^+ CD25^+T cells in patients with idiopathic thrombocytopenic purpura.Thromb Res,2007,120:187-190.
5Ma DX,Zhu XJ,Zhao P,et al.Profile of Th17 cytokines (IL-17,TGF-β,IL-6) and Th1 cytokine (IFN-r) in patients with immune thrombocytopenic purpura.Ann Hematol,2008,87:899-901.
6Zhou RF,Yang JQ,Chang DY,et al.Profiles of Th1,Th2,Th17 and Treg Cells in Patients with Chronic Idiopathic Thrombocytopenic Purpura.Blood (ASH Annual Meeting Abstracts),2008,112:4907.
8Li F,Zou SH,Cheng YF,et al.Elevated expression of IL-17 and IL-23 in patients with immune thrombocytopenic purpura.Blood (ASH Annual Meeting Abstracts),2008,112:3428.
9Zhang J,Ma D,Zhu X,et al.Elevated profile of Th17,Th1and Tc1 cells in patients with immune thrombocytopemc purpura.Haematologica,2009,94:1326-1329.
10ProvanD, StasiR, NewlandAC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia[J]. Blood,2010,115(2):168-186.
